Embolization Agent
Arterial Embolization for Osteoarthritis
Recruiting1 award
New York, New York
This trial is testing a new treatment where tiny beads are used to block certain blood vessels in the knee. It is aimed at people with mild to moderate knee osteoarthritis who might not benefit from usual treatments. The goal is to see if blocking these blood vessels can safely reduce pain and swelling.
Popular Filters
Trials for Hip Osteoarthritis Patients
Orthopedic Implant
Shoulder Replacement Device for Osteoarthritis
Recruiting1 award
Kingston
This trial is monitoring the safety and performance of a shoulder replacement device called the GLOBAL ICON stemless humeral component. The data will be used to make sure the device is safe and effective and to help make the case for it to be used more widely.
Orthopedic Implant
Persona Partial Knee Replacement for Osteoarthritis
Recruiting1 award
Fremont, California
This trial studies a knee implant called the Persona Partial Knee System in patients needing partial knee replacement. It aims to see how well the implant works and how long it lasts by tracking patients over time. The Persona® system is a newly launched implant designed for knee replacement with innovations intended for better function and higher flexibility.
Trials for OA Patients
Orthopedic Implant
Shoulder Replacement Device for Osteoarthritis
Recruiting1 award
Kingston
This trial is monitoring the safety and performance of a shoulder replacement device called the GLOBAL ICON stemless humeral component. The data will be used to make sure the device is safe and effective and to help make the case for it to be used more widely.
Orthopedic Implant
Persona Partial Knee Replacement for Osteoarthritis
Recruiting1 award
Fremont, California
This trial studies a knee implant called the Persona Partial Knee System in patients needing partial knee replacement. It aims to see how well the implant works and how long it lasts by tracking patients over time. The Persona® system is a newly launched implant designed for knee replacement with innovations intended for better function and higher flexibility.
Phase 3 Trials
Monoclonal Antibodies
RTX-GRT7039 Injections for Knee Osteoarthritis
Recruiting2 awardsPhase 3
Glendale, Arizona
This trial uses knee injections called RTX-GRT7039 for patients with knee osteoarthritis who still have pain despite usual treatments. The injections aim to reduce knee pain, possibly by affecting pain pathways or inflammation.
Procedure
TG-C for Osteoarthritis of the Knee
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial tests TG-C, an injection into the knee, for patients with moderate to severe osteoarthritis. It aims to reduce pain and improve knee function by potentially modifying the disease. TG-C has shown promise in previous studies for managing knee osteoarthritis.
Stem Cell Therapy
BMAC vs Triamcinolone for Hip Osteoarthritis
Recruiting2 awardsPhase 3
Weston, Florida
This trial compares two treatments for hip osteoarthritis: one that uses the patient's own bone marrow cells to promote healing, and another that uses a steroid to quickly reduce inflammation. The study aims to determine which treatment offers better long-term pain relief and improved mobility.
Non-Surgical Interventions for Knee Osteoarthritis
Recruiting2 awardsPhase 3
San Diego, California
This trial will compare commonly recommended treatments to reduce pain and functional limitations in KOA. The results will lead to improved patient selection for treatment and inform evidence based guidelines by offering well-tested, effective, non-surgical alternatives.
Procedure
TG-C for Knee Osteoarthritis
Recruiting1 awardPhase 3
Phoenix, Arizona
This trial tests TG-C, an injection into the knee, for people with moderate to severe knee osteoarthritis. It aims to see if TG-C can reduce pain and improve knee function by potentially altering the disease. The study will monitor patients for safety and effectiveness over time. TG-C has been previously studied for its potential to improve knee joint function and reduce pain in osteoarthritis patients.
Trials With No Placebo
Orthopedic Implant
Shoulder Replacement Device for Osteoarthritis
Recruiting1 award
Kingston
This trial is monitoring the safety and performance of a shoulder replacement device called the GLOBAL ICON stemless humeral component. The data will be used to make sure the device is safe and effective and to help make the case for it to be used more widely.
Orthopedic Implant
Persona Partial Knee Replacement for Osteoarthritis
Recruiting1 award
Fremont, California
This trial studies a knee implant called the Persona Partial Knee System in patients needing partial knee replacement. It aims to see how well the implant works and how long it lasts by tracking patients over time. The Persona® system is a newly launched implant designed for knee replacement with innovations intended for better function and higher flexibility.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.